A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease
一项针对轻度至中度阿尔茨海默病患者的AR1001（一种磷酸二酯酶-5抑制剂）疗效和安全性的II期随机、安慰剂对照研究
期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100337
Greeley, David; Nash, Marshall; Herskowitz, Brad; Kim, Fred; Rock, James; Prins, Neils; Kim, SangYun; Xi, Tianyang; Busam, Jonathan A; Tete, Benoit; Choung, Jai Jun; Sha, Sharon J
